Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1964271

Pique Therapeutics - Product Pipeline Review - H2 2011

Description:

Pique Therapeutics – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Pique Therapeutics - Product Pipeline Review - H2 2011” provides data on the Pique Therapeutics’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Pique Therapeutics’s corporate website, SEC filings, investor presentations and featured press releases, both from Pique Therapeutics and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Pique Therapeutics - Brief Pique Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pique Therapeutics human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Pique Therapeutics with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Pique Therapeutics’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Pique Therapeutics’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Pique Therapeutics in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Pique Therapeutics’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Pique Therapeutics.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Pique Therapeutics and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Pique Therapeutics; Pique Therapeutics - Key Therapeutics; Pique Therapeutics - Pipeline Overview and Promising Molecules; Pique Therapeutics - News; Pique Therapeutics - Latest Updates; Pique Therapeutics - Pipeline; Pique Therapeutics - Discontinued/Dormant Projects

Contents:

List of Tables
List of Figures
Pique Therapeutics Snapshot
Pique Therapeutics Overview
Key Information
Key Facts
Pique Therapeutics – Research and Development Overview
Key Therapeutic Areas
Pique Therapeutics – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pique Therapeutics – Pipeline Products Glance
Pique Therapeutics–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Pique Therapeutics – Drug Profiles
PT 123
Product Description
Mechanism of Action
R&D Progress
PT 207
Product Description
Mechanism of Action
R&D Progress
Pique Therapeutics – Pipeline Analysis
Pique Therapeutics – Pipeline Products by Therapeutic Class
Pique Therapeutics – Pipeline Products by Molecule Type
Pique Therapeutics – Recent Pipeline Updates
Pique Therapeutics – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Pique Therapeutics, Deals Summary
Pique Therapeutics, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Pique Therapeutics Secures $0.53 Million In Series A Round Of Financing
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Pique Therapeutics – Pipeline by Therapy Area and Indication, H2 2011
Pique Therapeutics – Pipeline by Stage of Development, H2 2011
Pique Therapeutics – Monotherapy Products in Pipeline, H2 2011
Pique Therapeutics - Pipeline By Therapeutic Class, H2 2011
Pique Therapeutics – Pipeline By Molecule Type, H2 2011
Pique Therapeutics – Recent Pipeline Updates, H2 2011
Pique Therapeutics, Deals Summary
Pique Therapeutics Secures $0.53 Million In Series A Round Of Financing

List of Figures
Pique Therapeutics – Pipeline by Therapy Area and Indication, H2 2011
Pique Therapeutics – Pipeline by Stage of Development, H2 2011
Pique Therapeutics – Monotherapy Products in Pipeline, H2 2011
Pique Therapeutics – Pipeline By Therapeutic Class, H2 2011

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2

Printed Friday, May 24, 2013
11:38:45 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Pique Therapeutics - Product Pipeline Review - H2 2011

Web Address

http://www.researchandmarkets.com/reports/1964271

Office Code

OC8DIQSMTMSSYS

Report Formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		EURO€ 384.00
Electronic (PDF) - Site License		EURO€ 769.00
Electronic (PDF) - Enterprisewide		EURO€ 1,153.00

Contact information

Please enter all the information below in block capitals.

                Title:
            
                    Mr
                    
                    Mrs
                    
                    Dr
                    
                    Miss
                    
                    Ms
                    
                    Prof
                    
                First Name:
            
                Last Name:
                
                Email Address:
            
                Job Title:
            
                Organisation:
            
                Address:
            
                City:
            
                Postal / Zip Code:	
            
                Country:	
            
                Phone Number:	
            
                Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2

Printed Friday, May 24, 2013
11:38:45 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:

Cardholder's Signature:

Expiry Date:

Card Number:

CVV Security Code:

Issue date:

(Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:

Account Number:

83313083

Sort Code:

98-53-30

Swift Code:

ULSBIE2D

IBAN Number:

IE78ULSB98533083313083

Bank Address:

Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Printer Friendly

Pique Therapeutics - Product Pipeline Review - H2 2011

Fax order form

Order information

Product name

Web Address

Office Code

Report Formats

Contact information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Payment information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)